Despite preclinical studies in breast cancer, hepatocellular carcinoma, leukemia, and prostate cancer that have shown the anti-cancer effect of TSN in various human malignancies, its clinical application in cancer treatment is limited because of liver injury when high concentrations of TSN were used in animal models. This evidence concerns the gene TSN and cancer.